Cooper Companies | COO - Assets


Cooper Companies reported $12.48B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Align Technology USD 6.31B 80.48M Mar/2026
AtriCure USD 643.99M 10.19M Mar/2026
Avanos Medical USD 1.05B 23.6M Mar/2026
Bausch Health Companies USD 24.5B 1.87B Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Bayer EUR 107.94B 3.4B Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Boston Scientific USD 44.35B 678M Mar/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Dexcom USD 6.63B 293.4M Mar/2026
Edwards Lifesciences USD 13.32B 376M Mar/2026
Globus Medical USD 5.44B 136.79M Mar/2026
Haemonetics USD 2.4B 94.96M Mar/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 2.99B 203.2M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
Intuitive Surgical USD 20.11B 347.7M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.72B 33.36M Mar/2026
Novartis USD 110.95B 3.66B Dec/2025
ResMed USD 8.78B 280.91M Mar/2026
STAAR Surgical USD 451.12M 560K Mar/2026
Steris USD 10.74B 145.8M Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
Utah Medical Products USD 122.54M 567K Dec/2025
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026